info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Brain, supratentorial

CD2_BENIGN_BRAIN_SUPRATENT_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D33.0
  • Cause of death: ICD-10 D33.0

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D33
Name in latin
Neoplasma benignum cerebri supratentoriale

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 587 339 248
Unadjusted period prevalence (%) 0.11 0.12 0.11
Median age at first event (years) 50.38 46.72 55.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
533
Matched controls
5328
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
271.5
221.2
213
13
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
202.3
181
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
33.3
197.4
271
160
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
135.3
124
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1135.6
99.4
94
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
94.6
88
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
16.0
81.5
139
115
H02AB02
ATC
dexamethasone; systemic
51.6
78.6
94
22
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
73.7
69
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
60.3
70.6
82
16
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.8
69.0
152
208
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
20.8
62.7
95
55
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
60.6
57
*
N03AF02
ATC
oxcarbazepine; oral
17.6
57.9
93
63
AA1AD
NOMESCO Finland
CT of head and brain
4.9
53.0
220
673
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
195.6
51.9
53
*
D33.30
ICD-10 Finland
Acoustic neuroma
89.3
51.0
56
7
N03AX14
ATC
levetiracetam; systemic
18.1
46.8
74
47
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.8
46.7
69
36
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
23.3
45.7
66
32
130
Kela drug reimbursment
Malignant tumour
+∞
45.5
43
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
78.4
44.8
50
7
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
47.8
43.1
52
12
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
19.3
42.3
65
38
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
19.1
40.9
63
37
G91.1
ICD-10 Finland
Obstructive hydrocephalus
151.5
40.3
42
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
38.0
36
*
ZXC95
NOMESCO Finland
Use of surgical navigator
36.6
36.9
47
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.2
32.9
142
420
WF002
NOMESCO Finland
Radical radiotherapy
331.2
31.2
31
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.4
30.2
69
93
A04AA02
ATC
granisetron; systemic, transdermal
319.5
30.1
30
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
32.2
29.9
39
13
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.5
29.4
62
73
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
21.6
28.7
42
21
D33.04
ICD-10 Finland
Temporal lobe
+∞
25.2
24
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.2
24
*
R51.80
ICD-10 Finland
Headache
3.5
25.0
138
488
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
73.5
25.0
28
*
XCK00
NOMESCO Finland
Perimetry
5.6
24.9
77
157
C61
ICD-10 Finland
Malignant neoplasm of prostate
94.6
24.9
27
*
N03AB02
ATC
phenytoin; systemic
39.6
24.2
30
8
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
24.1
23
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.0
24.1
69
128
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
250.7
23.8
24
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
23.3
23.3
33
15
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
23.1
22
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
23.1
22
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
31.7
23.0
30
10
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
22.0
21
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
21.9
133
502
N03AF01
ATC
carbamazepine; oral, rectal
6.3
21.1
58
102
L01AX03
ATC
temozolomide; systemic
+∞
21.0
20
*
H53.4
ICD-10 Finland
Visual field defects
11.3
20.7
39
37
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
218.1
20.7
21
*
N03AG01
ATC
valproic acid; systemic, rectal
4.7
20.1
72
172
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
19.6
167
773
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
47.9
19.3
23
5
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
72.5
18.8
21
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
17.8
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
17.8
17
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
16.3
17.7
28
18
H02AB09
ATC
hydrocortisone; systemic
10.6
17.1
33
33
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
26.6
17.0
23
9
183
Kela drug reimbursment
Lamotrigin and topiramate
15.7
16.8
27
18
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
16.7
16
*
WX882
NOMESCO Finland
High dependency care
7.4
16.4
39
56
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
16.4
49
96
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
34.5
15.8
20
6
G93.0
ICD-10 Finland
Cerebral cysts
34.5
15.8
20
6
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
15.7
15
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
15.7
15
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
164.5
15.6
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
164.5
15.6
16
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
15.5
96
360
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
14.6
14
*
2152
FHL
Extraction, big brain
+∞
14.6
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
82.4
14.6
16
*
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
82.4
14.6
16
*
E23.00
ICD-10 Finland
Panhypopituitarism
82.4
14.6
16
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
154.0
14.5
15
*
N03AX18
ATC
lacosamide; systemic
13.9
14.3
24
18
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.8
14.3
62
177
AA1BD
NOMESCO Finland
Extensive CT of head and brain
9.8
14.1
28
30
116
Kela drug reimbursment
Prostate cancer
+∞
13.6
13
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
13.6
13
*
D32.03
ICD-10 Finland
Benign meningioma in ventricles
+∞
13.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
143.4
13.5
14
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
143.4
13.5
14
*
R4110
NOMESCO Finland
Physiotherapy
2.3
13.3
146
752
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
12.6
13.2
23
19
N05BA09
ATC
clobazam; oral
19.6
13.0
19
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
12.7
114
529
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
71.6
12.6
14
*
N76
ICPC
Neoplasm nervous system unspecified
71.6
12.6
14
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
71.6
12.6
14
*
ZXC40
NOMESCO Finland
Use of ultrasound
32.9
12.6
16
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
32.9
12.6
16
5
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
12.5
12
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
12.5
12
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
12.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
132.9
12.5
13
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
10.9
12.4
23
22
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
15.1
11.9
19
13
N88
ICPC
Epilepsy
16.9
11.7
18
11
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
11.5
11
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
122.5
11.5
12
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
11.5
35
71
G40.10
ICD-10 Finland
Simple partial seizures
15.5
11.4
18
12
AAF00
NOMESCO Finland
Ventriculostomy
20.6
11.2
16
8
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
11.1
65
234
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
14.3
11.0
18
13
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
61.2
10.7
12
*
N75
ICPC
Benign neoplasm nervous system
112.1
10.5
11
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
112.1
10.5
11
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
112.1
10.5
11
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
10.4
10
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
10.4
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
10.4
10
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
10.4
10
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
10.1
52
171
101
Kela drug reimbursment
Anterior pituitary hypofunction
14.9
10.0
16
11
G40
ICD-10 Finland
Epilepsy
14.9
10.0
16
11
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.9
123
660
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
26.6
9.8
13
5
L02AE02
ATC
leuprorelin; implant, parenteral
10.9
9.8
18
17
JN4AD
NOMESCO Finland
Body CT examination
5.7
9.8
27
49
WF099
NOMESCO Finland
Other radiotherapy
101.7
9.4
10
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
101.7
9.4
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
9.4
157
946
N03AX09
ATC
lamotrigine; oral
3.9
9.4
38
103
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
9.4
9
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
9.4
9
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
9.4
9
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
9.4
9
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
9.4
59
223
A04AA01
ATC
ondansetron; systemic, rectal
5.9
9.3
25
44
H53.2
ICD-10 Finland
Diplopia
5.0
9.3
29
61
TAB00
NOMESCO Finland
Lumbar puncture
3.7
9.3
40
115
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
9.3
71
301
ZXC86
NOMESCO Finland
Use of endoscopic device
19.0
9.0
13
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
9.0
80
368
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.5
8.9
12
5
R51
ICD-10 Finland
Headache
3.6
8.9
39
114
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
8.8
42
131
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.7
202
1356
JN4CD
NOMESCO Finland
Very extensive body CT
8.4
8.6
18
22
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
11.8
8.6
15
13
XKD00
NOMESCO Finland
Uroflowmetry
2.4
8.6
73
328
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
20.4
8.5
12
6
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
20.4
8.5
12
6
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
91.4
8.4
9
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
91.4
8.4
9
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
91.4
8.4
9
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
8.4
8
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
8.4
8
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.0
8.3
15
14
G91.0
ICD-10 Finland
Communicating hydrocephalus
14.8
8.2
13
9
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.6
8.1
61
255
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
8.1
58
236
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
22.4
8.0
11
5
N02BE01
ATC
paracetamol; systemic, rectal
1.9
8.0
428
3658
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
13.3
7.9
13
10
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.3
7.9
28
68
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.6
7.9
16
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
7.8
70
323
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
45.6
7.7
9
*
HAC20
NOMESCO Finland
Total mastectomy
45.6
7.7
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.6
100
546
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
25.4
7.6
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.6
114
655
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
81.1
7.4
8
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
7.3
7
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
7.3
7
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
7.3
7
*
ZZC00
NOMESCO Finland
Graft of fascia
+∞
7.3
7
*
D33.11
ICD-10 Finland
Brain stem
+∞
7.3
7
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
30.4
7.2
9
*
L02BA01
ATC
tamoxifen; oral
20.3
7.2
10
5
D18.0
ICD-10 Finland
Haemangioma, any site
6.2
7.1
18
30
WX110
NOMESCO Finland
Local anesthesy
1.7
7.1
356
2914
WX402
NOMESCO Finland
General anaesthesia
2.2
7.1
75
375
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
6.9
117
700
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.8
6.9
16
24
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
16.9
6.8
10
6
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.7
76
391
H47.2
ICD-10 Finland
Optic atrophy
10.2
6.6
12
12
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
70.6
6.4
7
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
70.6
6.4
7
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
6.4
53
233
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.3
6.4
13
16
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
6.3
6
*
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
+∞
6.3
6
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
+∞
6.3
6
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
6.3
6
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
+∞
6.3
6
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
6.3
71
364
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.0
6.2
8
*
A02BC02
ATC
pantoprazole; systemic
1.6
6.2
303
2423
N05AX08
ATC
risperidone; systemic
2.4
6.1
49
214
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.3
6.1
28
87

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
132
8.29
65.46
1.2
1.3
—
—
—
0
0
146
411
4.40
47.72
6.8
7.9
1.4
1.4
mmol/l
0.07
105
327
145
414
4.32
46.42
6.8
7.8
5.1
5.2
kpa
0.48
136
399
145
414
4.32
46.42
6.8
7.8
15.9
12.3
kpa
6.80
135
401
357
1977
3.06
37.93
7.5
5.5
1.2
1.2
mmol/l
1.81
335
1690
331
1782
2.97
36.62
7.0
5.0
1.2
1.2
mmol/l
3.81
313
1593
38
39
10.35
33.31
2.5
1.3
—
—
—
0
0
52
114
4.91
22.64
2.3
1.2
2750.9
282.9
e6/l
0.73
44
95
52
114
4.91
22.64
2.2
1.1
16.2
3.4
e6/l
0.89
44
92
51
112
4.89
22.15
2.0
1.2
3.5
3.8
mmol/l
0.69
46
104
48
101
5.09
21.90
2.3
1.2
—
—
—
0
0
376
2563
2.30
20.33
6.3
4.2
6.4
6.7
mmol/l
1.86
360
2348
31
47
6.91
19.76
1.9
1.1
—
—
—
0
0
253
1485
2.24
19.54
2.4
1.6
—
—
—
0
0
106
425
2.82
18.72
3.4
1.8
302.6
365.9
nmol/l
2.63
97
385
189
999
2.32
18.62
3.7
3.2
94.4
91.1
%
1.17
183
968
216
1211
2.24
18.44
2.3
2.0
—
—
—
0
0
230
1326
2.21
18.30
2.6
2.1
273.7
276.6
u/l
0.01
222
1250
72
244
3.22
17.03
6.7
6.7
—
—
—
0
0
175
933
2.25
16.61
2.3
2.0
—
—
—
0
0
297
1953
2.05
16.18
3.7
3.7
—
—
—
0
0
130
619
2.41
15.99
2.3
1.8
28.1
29.7
s
3.72
130
600
296
2048
1.90
12.93
6.7
3.8
9.6
12.0
umol/l
5.40
279
1925
342
2492
1.89
12.59
9.8
6.4
4.3
4.1
e9/l
0.36
296
2191
251
1660
1.89
12.48
4.9
3.7
35.6
36.3
g/l
1.06
234
1544
51
169
3.21
12.47
4.6
4.5
—
—
—
0
0
26
53
5.09
12.26
2.1
1.1
—
—
—
0
0
30
71
4.40
11.87
5.2
4.7
373.7
386.1
umol/l
0.16
25
61
187
1144
1.93
11.62
4.4
2.9
7.4
7.4
ph
1.20
21
189
110
567
2.16
10.91
3.4
3.0
0.8
0.8
mmol/l
0.27
104
531
236
1594
1.80
10.51
6.2
8.5
1.1
1.2
inr
1.27
59
479
167
1022
1.89
10.16
6.4
4.8
—
—
—
0
0
413
3314
1.83
9.97
8.2
5.2
76.6
76.2
u/l
0.06
391
3066
302
2245
1.71
9.24
6.7
5.4
0.6
0.6
e9/l
0.34
258
1964
308
2319
1.69
8.85
6.7
5.4
1.8
1.9
e9/l
1.62
265
2064
309
2333
1.69
8.74
6.8
5.7
0.2
0.2
e9/l
1.27
270
2077
195
1300
1.75
8.74
2.9
1.9
2.3
2.4
mmol/l
0.82
164
1108
301
2258
1.68
8.72
6.7
5.4
0.0
0.0
e9/l
0.73
257
1981
68
322
2.26
8.24
8.3
6.9
—
—
—
0
0
39
141
2.89
8.23
2.6
1.4
7.7
9.0
u/l
0.20
30
113
19
42
4.64
8.17
1.3
1.5
279.7
281.0
mosm/kgh2o
0.09
14
28
19
42
4.64
8.17
1.7
1.7
—
—
—
0
0
159
1025
1.76
7.90
4.7
3.3
—
—
—
0
0
70
354
2.11
7.20
4.6
3.0
—
—
—
0
0
43
176
2.56
7.18
11.5
12.1
—
—
—
0
0
44
187
2.46
6.80
3.4
1.5
4.6
4.2
ug/l
0.07
35
140
179
1236
1.64
6.74
3.6
2.8
—
—
—
0
0
71
372
2.03
6.65
1.2
1.1
—
—
—
0
0
222
1626
1.59
6.52
3.6
3.4
49.1
58.3
ng/l
0.13
152
1047
15
34
4.50
6.27
1.1
1.2
—
—
—
0
0
430
3685
1.62
6.22
4.9
3.9
14.5
14.6
pmol/l
0.24
404
3359
199
1434
1.59
6.21
7.3
5.4
—
—
—
0
0
524
4750
1.96
6.08
17.7
10.7
23.5
20.9
mg/l
1.10
452
3575
144
968
1.65
5.94
4.7
3.7
—
—
—
0
0
87
516
1.81
5.61
6.1
4.9
1.0
1.1
mmol/l
0.18
77
471
260
2023
1.51
5.59
6.7
5.6
0.7
0.7
%
0.04
243
1891
80
467
1.83
5.43
1.7
1.7
—
—
—
0
0
90
546
1.77
5.38
1.6
1.6
—
—
—
0
0
60
323
1.96
5.22
2.4
2.5
10.4
10.7
g/l
0.20
55
299
153
1085
1.55
4.95
3.7
2.7
—
—
—
0
0
263
2095
1.46
4.82
6.7
5.5
2.7
3.0
%
1.12
247
1956
30
127
2.44
4.73
2.7
1.6
1.7
1.7
ug/l
0.00
23
113
398
3443
1.48
4.69
4.7
4.0
10.9
10.2
mm/h
0.39
372
3176
263
2104
1.45
4.67
7.0
5.8
8.7
8.4
%
0.69
248
1976
116
783
1.60
4.62
3.0
2.5
559.8
556.1
mosm/kgh2o
0.06
100
647
197
1493
1.48
4.61
4.1
3.3
41.9
96.2
e6/l
1.24
146
1005
123
845
1.58
4.54
2.7
2.3
4.0
6.8
e6/l
1.58
111
727
43
221
2.02
4.28
2.4
1.3
26.4
24.1
iu/l
0.15
37
185
266
2167
1.42
4.12
6.8
5.5
27.6
29.2
%
1.49
251
2033
264
2150
1.41
4.09
6.4
5.3
57.5
56.4
%
0.79
249
2022
15
48
3.18
3.95
2.2
2.2
—
—
—
0
0
15
48
3.18
3.95
2.1
1.3
—
—
nmol/l
—
0
0
63
378
1.75
3.92
3.9
3.3
—
—
—
0
0
55
317
1.81
3.91
2.7
2.3
12.5
14.1
nmol/l
0.81
50
286
221
1757
1.41
3.88
2.1
1.9
93.7
96.2
pmol/l
0.34
108
911
103
704
1.56
3.86
2.9
1.9
2.4
2.4
mmol/l
0.43
89
605
365
3165
1.41
3.82
3.7
3.5
—
—
—
0
0
538
5045
1.80
3.82
16.4
10.3
—
—
—
0
0
149
1106
1.47
3.78
3.9
2.8
0.3
0.4
e6/l
0.67
122
806
80
518
1.63
3.76
17.5
20.7
1.5
1.2
inr
0.64
12
80
362
3144
1.39
3.70
4.9
3.9
—
—
—
0
0
174
1336
1.43
3.67
2.9
2.2
55.9
57.9
u/l
0.29
157
1237
162
1228
1.44
3.67
3.7
2.8
39.1
115.9
e6/l
0.72
136
923
142
1052
1.46
3.62
5.1
3.4
1.0
1.0
kg/l
0.36
22
140
17
63
2.75
3.52
2.5
1.5
—
—
—
0
0
13
41
3.22
3.51
1.4
1.1
—
—
—
0
0
55
328
1.75
3.51
1.6
1.5
—
—
—
0
0
6
6
10.09
3.50
1.3
1.2
2.4
7.7
nmol/l
—
6
6
540
5089
1.76
3.49
12.2
8.2
27.4
26.3
u/l
0.57
527
4889
139
1814
0.69
3.47
2.7
2.7
—
—
—
0
0
52
307
1.76
3.44
3.4
2.4
0.2
0.2
g/l
0.57
46
284
274
2295
1.36
3.39
4.6
3.3
0.0
0.0
estimate
0.50
39
380
156
1195
1.42
3.30
5.2
3.5
0.0
0.0
estimate
0.69
38
388
105
747
1.49
3.27
1.9
1.7
1101.4
1187.8
nmol/l
0.51
85
568
8
15
5.39
3.20
6.5
2.2
1.8
3.6
nmol/l
—
8
15
18
73
2.51
3.15
1.9
1.5
0.2
0.4
nmol/l
1.03
12
62
15
56
2.72
3.08
2.2
1.3
0.7
0.5
nmol/l
0.57
15
51
244
2030
1.35
3.07
9.4
7.6
0.0
0.0
e9/l
0.10
186
1670
10
29
3.49
3.06
3.8
2.5
—
—
—
0
0
47
280
1.74
3.03
2.9
3.8
5.0
5.1
kpa
0.36
41
266
268
2266
1.34
3.00
6.0
4.5
0.0
0.0
estimate
0.00
39
395
33
177
1.92
2.97
1.8
1.8
—
—
—
0
0
266
2250
1.33
2.96
4.7
3.3
0.0
0.0
estimate
0.00
41
394
14
52
2.73
2.90
2.2
1.3
—
—
—
0
0
93
665
1.47
2.82
1.3
1.4
378.2
541.9
titre
0.98
22
146
37
212
1.80
2.74
3.1
3.9
—
—
—
0
0
7
14
5.05
2.73
1.7
1.9
26.5
16.2
umol/l
—
7
14
140
1090
1.37
2.64
2.8
2.1
2.8
2.9
mg/l
0.28
117
927
46
284
1.67
2.64
2.9
2.4
—
—
—
0
0
72
497
1.51
2.60
1.4
1.4
—
—
—
0
0
8
20
4.04
2.57
1.3
1.1
33.1
27.6
mmol/l
—
8
20
15
62
2.46
2.56
1.1
1.1
—
—
—
0
0
476
4434
1.39
2.50
5.5
4.5
2.0
2.1
mu/l
0.24
440
4076
58
386
1.56
2.47
4.6
3.3
2.1
1.9
mmol/l
0.16
50
307
19
90
2.15
2.41
2.1
2.0
—
—
—
0
0
15
64
2.38
2.40
1.3
1.2
—
—
—
0
0
212
1787
1.29
2.28
4.7
3.1
—
—
—
0
0
6
13
4.65
2.27
1.5
1.1
—
—
—
0
0
8
23
3.51
2.27
2.0
2.6
—
—
—
0
0
17
334
0.49
2.23
1.3
1.4
—
—
—
0
0
16
73
2.23
2.23
1.3
1.2
4.6
7.3
u/ml
—
10
35
5
9
5.59
2.21
1.2
1.0
—
—
—
0
0
10
36
2.81
2.21
2.6
4.1
—
—
—
0
0
156
1267
1.31
2.20
1.4
1.5
—
—
—
0
0
14
61
2.33
2.16
2.2
2.5
—
—
—
0
0
55
374
1.52
2.15
3.1
2.5
7.0
7.0
ug/l
0.01
49
329
14
290
0.47
2.14
1.4
1.7
—
—
—
0
0
47
310
1.56
2.11
2.8
2.4
57.4
67.1
e9/l
1.51
37
235
560
5418
1.73
2.09
26.8
15.9
4.5
4.6
e12/l
2.48
555
5253
11
44
2.53
2.02
1.1
1.2
—
—
—
0
0
42
273
1.58
2.01
1.9
1.5
68.5
67.9
g/l
0.21
36
244
125
998
1.32
1.98
1.6
1.5
20.2
21.0
nmol/l
0.17
107
857
18
91
2.01
1.97
1.2
1.2
—
—
—
0
0
11
45
2.47
1.94
1.2
1.7
3.0
95.9
u/ml
0.49
11
40
105
821
1.34
1.92
3.7
3.5
80.2
372.9
ng/l
2.73
73
590
7
22
3.21
1.88
1.0
1.0
1556.7
1740.5
miu/ml
—
7
22
102
797
1.34
1.87
1.6
1.7
—
—
—
0
0
59
422
1.44
1.83
2.7
2.2
1.6
1.7
%
0.23
50
382
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
11
47
2.37
1.78
2.3
2.4
—
—
—
0
0
37
550
0.65
1.77
1.4
1.4
—
—
—
0
0
240
2114
1.23
1.66
3.1
2.7
106.0
99.6
ug/l
0.26
217
1965
20
113
1.80
1.62
1.9
3.1
—
—
—
0
0
79
608
1.35
1.61
3.1
2.3
13.3
13.9
umol/l
0.30
70
561
35
235
1.52
1.50
2.1
1.4
—
—
—
0
0
20
116
1.75
1.50
4.5
1.8
—
—
—
0
0
13
65
2.02
1.49
1.3
1.4
—
—
—
0
0
42
294
1.46
1.48
4.9
3.8
89.7
77.5
ng/l
0.32
34
263
72
554
1.34
1.48
2.3
2.0
—
—
—
0
0
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
133
1117
1.25
1.41
2.4
2.3
331.5
6339.3
umol/l
3.97
117
984
7
29
2.43
1.39
1.1
1.2
—
—
—
0
0
16
89
1.82
1.38
1.6
1.2
—
—
—
0
0
31
207
1.53
1.38
4.4
3.1
—
—
—
0
0
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
65
500
1.34
1.35
3.5
2.4
20.8
24.2
%
1.38
54
437
118
985
1.25
1.32
2.0
1.7
1.4
1.1
mg/l
0.53
90
727
19
114
1.69
1.29
6.2
4.4
1.2
1.4
mg/l
1.04
19
104
29
194
1.52
1.29
3.7
1.6
—
—
—
0
0
13
70
1.88
1.24
2.3
2.5
18.2
16.3
%
—
7
35
8
37
2.18
1.22
1.1
1.1
—
—
—
0
0
25
369
0.66
1.21
5.0
3.2
—
—
—
0
0
13
71
1.85
1.20
3.5
4.0
—
—
—
0
0
75
605
1.27
1.13
1.2
1.2
—
—
—
0
0
31
218
1.45
1.11
2.1
2.4
0.2
0.2
e6/l
0.34
31
208
35
252
1.41
1.11
1.5
1.2
—
—
—
0
0
40
295
1.38
1.11
4.3
4.6
0.0
0.1
%
1.62
13
65
119
1016
1.21
1.09
1.8
1.9
—
—
—
0
0
123
1054
1.21
1.09
5.0
4.1
—
—
—
0
0
39
288
1.38
1.08
3.7
4.6
0.6
0.4
%
—
10
56
11
59
1.88
1.08
1.4
1.3
—
—
—
0
0
106
896
1.22
1.07
1.6
1.6
438.2
19522347.8
pmol/l
1.06
92
753
14
82
1.72
1.06
1.0
2.0
143.3
131.0
g/l
—
9
58
41
307
1.36
1.05
4.3
4.5
0.5
0.7
%
0.68
13
71
9
48
1.89
1.01
1.4
1.3
—
—
—
0
0
9
49
1.85
0.99
1.4
1.3
7.5
6.1
g/l
—
9
33
9
49
1.85
0.99
1.4
1.3
2.9
2.8
g/l
—
9
32
0
32
0.00
0.95
0.0
1.2
—
33.8
—
0
27
23
158
1.47
0.95
1.3
1.2
—
—
—
0
0
8
142
0.56
0.94
1.4
1.5
—
—
—
0
0
17
109
1.58
0.94
3.1
1.6
—
—
—
0
0
12
71
1.70
0.89
2.3
1.3
—
—
—
0
0
67
553
1.24
0.87
3.3
2.3
2.3
2.4
g/l
0.16
59
515
8
45
1.79
0.84
1.6
2.6
—
—
—
0
0
8
137
0.58
0.84
1.4
1.4
—
—
—
0
0
27
198
1.38
0.81
3.0
2.3
—
—
—
0
0
144
1286
1.16
0.80
4.9
3.7
4.0
1.9
ug/l
0.90
128
1154
31
234
1.34
0.79
1.2
1.2
—
167.3
—
0
7
0
24
0.00
0.79
0.0
1.6
—
1.1
—
0
17
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
6
33
1.83
0.79
2.2
1.1
—
—
—
0
0
46
368
1.27
0.78
1.1
1.2
174.8
145.0
iu/ml
0.16
18
163
114
1291
0.85
0.78
4.0
2.8
—
—
—
0
0
36
281
1.30
0.74
4.6
4.8
0.0
0.1
%
0.60
11
56
8
136
0.58
0.73
1.4
1.4
—
—
—
0
0
100
874
1.17
0.73
1.3
1.3
37.4
31.2
iu/ml
0.11
27
266
5
25
2.01
0.73
1.2
1.6
—
2310.6
—
0
5
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
134
1201
1.15
0.71
3.8
3.6
—
—
—
0
0
24
178
1.36
0.70
1.4
1.3
179.0
263.0
miu/ml
—
10
88
30
232
1.31
0.67
3.6
1.8
—
—
—
0
0
5
28
1.79
0.66
1.2
1.4
3.9
6.1
ug/l
—
5
23
11
70
1.58
0.65
2.5
3.6
—
—
—
0
0
13
87
1.51
0.63
3.8
2.1
109.2
148.2
u/ml
0.12
13
69
40
326
1.24
0.61
1.5
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
3233.0
—
0
11
0
21
0.00
0.60
0.0
1.1
—
3225.4
—
0
12
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
52
439
1.20
0.58
1.4
1.3
—
—
—
0
0
9
60
1.51
0.54
1.9
1.6
—
—
—
0
0
22
169
1.31
0.54
6.8
2.1
—
—
—
0
0
82
727
1.15
0.53
2.7
2.6
0.8
0.7
ug/l
0.36
53
449
31
252
1.24
0.50
3.5
1.8
—
—
—
0
0
10
67
1.50
0.50
1.0
1.1
—
—
—
0
0
31
253
1.24
0.49
3.5
1.8
—
—
—
0
0
52
448
1.18
0.48
3.2
2.4
8.6
7.3
umol/l
0.18
40
390
7
48
1.46
0.47
2.7
1.8
91.2
90.4
%
—
7
48
416
4044
1.10
0.46
20.7
12.9
13.6
13.5
%
0.82
416
3949
37
312
1.20
0.44
6.2
2.6
3.6
4.0
e9/l
0.43
27
245
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
5
32
1.57
0.42
1.6
2.8
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
30
251
1.21
0.40
3.6
1.8
—
—
—
0
0
8
61
1.32
0.39
1.6
1.2
—
—
—
0
0
23
187
1.24
0.39
1.1
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
18
142
1.28
0.39
2.1
1.9
36.3
38.2
nmol/l
0.15
18
136
18
143
1.27
0.37
1.2
1.2
—
2.9
—
0
16
52
585
0.88
0.36
1.2
1.5
—
—
—
0
0
41
469
0.86
0.36
1.3
1.4
—
—
—
0
0
11
81
1.36
0.36
3.7
3.1
4.2
4.1
e9/l
0.07
11
81
11
82
1.35
0.34
4.1
3.4
60.6
56.3
%
0.56
11
82
464
4712
0.93
0.29
4.5
4.2
4.7
4.7
mmol/l
0.41
439
4394
10
76
1.32
0.28
1.4
1.2
—
—
—
0
0
17
140
1.22
0.27
1.2
1.2
—
—
—
0
0
44
398
1.11
0.24
1.2
1.2
—
—
—
0
0
28
318
0.87
0.24
1.3
1.2
—
—
—
0
0
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
2387.2
172000.0
e6/l
—
5
27
152
1456
1.06
0.23
4.4
3.2
8.1
7.8
mmol/l
0.25
132
1238
25
219
1.15
0.22
1.0
1.1
—
—
—
0
0
10
79
1.27
0.22
1.0
1.6
—
—
—
0
0
5
42
1.19
0.21
3.6
2.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
1.4
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
426
4322
0.95
0.21
5.9
5.5
38.3
39.6
mmol/mol
2.64
395
4034
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
15
126
1.20
0.21
2.0
1.9
2.0
6.4
iu/l
—
6
44
13
108
1.21
0.20
2.2
1.9
177.4
234.8
pmol/l
0.88
13
100
463
4684
0.95
0.20
4.5
4.2
1.5
1.5
mmol/l
0.55
433
4346
6
51
1.18
0.19
6.2
2.7
—
—
—
0
0
454
4485
1.05
0.19
19.9
11.7
39.4
40.5
%
2.01
320
3370
28
251
1.12
0.19
3.8
1.8
—
—
—
0
0
17
147
1.16
0.18
2.3
3.0
0.3
0.3
g/l
—
8
55
465
4600
1.05
0.17
4.8
4.2
5.7
5.9
mmol/l
2.86
424
4197
134
1290
1.05
0.17
3.4
3.3
38.1
213.5
mg/l
1.27
95
811
474
4787
0.95
0.17
5.0
4.7
2.8
2.8
mmol/l
0.03
442
4442
35
321
1.10
0.16
2.9
3.1
173.5
184.8
ng/l
0.05
30
295
121
1164
1.05
0.16
1.5
1.3
1.0
2.3
u/ml
1.11
28
312
11
130
0.84
0.16
1.1
1.1
—
—
—
0
0
447
4517
0.96
0.16
4.0
3.8
1.2
1.3
mmol/l
0.41
417
4173
104
1000
1.05
0.14
1.6
1.3
2.4
2.4
g/l
0.01
60
611
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
89
860
1.04
0.10
1.3
1.3
4.3
10.4
u/ml
1.00
35
333
5
44
1.14
0.10
1.2
1.9
—
—
—
0
0
5
48
1.04
0.09
1.0
3.4
6.0
6.6
mmol/l
—
5
35
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
60
578
1.04
0.08
1.7
1.7
—
—
—
0
0
59
611
0.96
0.07
1.4
1.7
—
—
—
0
0
6
72
0.83
0.07
1.3
1.2
—
—
—
0
0
8
74
1.08
0.07
1.0
1.2
—
75.1
—
0
5
7
83
0.84
0.07
1.4
1.6
—
—
—
0
0
17
157
1.09
0.07
8.5
9.1
—
—
—
0
0
13
118
1.10
0.07
1.2
1.2
0.1
3.0
u/ml
—
5
54
62
604
1.03
0.05
2.8
2.4
104.0
105.1
ug/g
0.01
46
470
12
110
1.09
0.05
1.6
1.4
300.3
319.1
ug/g
—
7
62
12
129
0.93
0.03
1.0
1.2
—
—
—
0
0
11
102
1.08
0.03
1.0
1.1
0.1
0.8
u/ml
—
5
54
123
1238
0.99
0.01
1.7
1.6
1.5
1.4
mmol/l
0.50
109
1052
137
1362
1.01
0.01
4.1
4.1
6.5
9.3
mg/mmol
0.43
93
860
11
105
1.05
0.00
1.0
1.1
1.1
5.3
u/ml
—
6
64
23
235
0.98
0.00
1.0
1.1
—
—
—
0
0
13
127
1.02
0.00
1.2
1.2
—
—
—
0
0
17
173
0.98
0.00
1.4
1.6
—
—
—
0
0
11
109
1.01
0.00
7.8
3.7
—
—
—
0
0
12
119
1.01
0.00
1.5
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
9
90
1.00
0.00
9.4
2.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
0.00
3.6
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
3.0
—
19.8
—
0
6
0
7
0.00
0.00
0.0
1.3
—
1.7
—
0
7
7
69
1.01
0.00
1.9
1.5
—
—
—
0
0
5
58
0.86
0.00
3.6
2.3
105.6
105.7
mmol/l
—
5
58
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
170.7
—
0
9
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
3.6
2.3
3.7
4.1
mmol/l
—
5
58
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
5.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
16.0
—
0
6
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
16.4
—
0
8

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT_EXALLC – Benign neoplasm: Brain, supratentorial

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).